Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Most ischemic stroke patients are in recovery phase, often accompanied by motor impairment,
but they lack effective treatment. The appearance of nerve growth factor (NGF) promotes the
development of neuroprotective therapy, but it has little effect on stroke because of the
blood-brain barrier (BBB). Electroacupuncture (EA) has been used for stroke, while there is
no significant clinical effect for recovery phrase. Consequently, we will conduct a
multicentre, randomised, controlled, assessor-blinded clinical trial to assess the
effectiveness and safety of EA combined with NGF treatment on ischemic stroke recovery.
Phase:
N/A
Details
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University